[ORGANIZATION]
ARISE trial
Featured in 1 tracked story · first seen
Also covered in
-
Solengepras meets primary endpoint in Phase 3 Parkinson’s disease trial
[HEALTH] · 2 sources ·
[ORGANIZATION]
Featured in 1 tracked story · first seen
[HEALTH] · 2 sources ·